Neuroinflammation

May 18, 2020

Mercaptor Discoveries Uses its Proprietary Neurotherapeutic Platform to Develop Treatment for COVID-19

May 05, 2020

Journal of Neuroinflammation Article Shows ZyVersa's Inflammasome Inhibitor, IC 100, Improves Functional Outcomes in an Animal Model of Multiple Sclerosis

Apr 13, 2020

Toxic Cell Atlas Guides New Therapies for Neurodegeneration

Dec 23, 2019

Carbiotix Signs Collaboration Agreement With Academic Partner Focused on Neuroinflammation

Aug 13, 2019

New Partnership to Define Neuroinflammatory Progression in Neurodegenerative Diseases

May 13, 2019

4D Announces Participation in Neuro4D Conference, Frankfurt, Germany

Sep 24, 2018

Noxopharm Subsidiary Announces Important Drug Discovery

Jan 31, 2018

A new publication confirms AZTherapies's innovative drug combination approach to address the neuroinflammation response via neuro-immunology and amyloid beta accumulation associated with neurodegeneration and Alzheimer's disease.

Dec 20, 2017

IFM Therapeutics LLC Appoints Dr. Michael Heneka to Clinical Advisory Board

Oct 31, 2017

AZTherapies, Inc. appoints Karen Reeves, MD as President and Chief Medical Officer

Sep 13, 2017

18th Annual Conference on Alzheimer's Drug Discovery Showcases Non-Amyloid Research

Sep 13, 2017

Neuraltus Pharmaceuticals and the University of Hawaii at Manoa Announce Initiation of Phase 1b Study of NP001 in Patients with Mild-to-Moderate Alzheimer's Disease